MSU
EW icon

Mizuho Securities USA’s Edwards Lifesciences EW Stock Holding History

Mizuho Securities USA’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08M Buy
45,079
+9,997
+28% +$837K 0.07% 286
2026
Q1 		$2.81M Sell
35,082
-7,172
-17% -$591K 0.07% 317
2025
Q4 		$3.66M Sell
42,254
-507
-1% -$41.6K 0.06% 278
2025
Q3 		$3.48M Buy
42,761
+2,216
+5% +$173K 0.07% 276
2025
Q2 		$3.17M Sell
40,545
-6,680
-14% -$498K 0.07% 283
2025
Q1 		$3.42M Sell
47,225
-8,675
-16% -$621K 0.07% 275
2024
Q4 		$4.14M Buy
55,900
+16,838
+43% +$1.18M 0.08% 253
2024
Q3 		$2.58M Sell
39,062
-7,396
-16% -$537K 0.06% 297
2024
Q2 		$4.29M Buy
+46,458
New +$4.11M 0.09% 202

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Mizuho Securities USA's EW Position: Q2 2026 in Review

Mizuho Securities USA increased its Edwards Lifesciences (EW) stake by 28% in Q2 2026, buying an estimated $837K and bringing the position to 45,079 shares worth $4.08M. The position accounts for 0.07% of the portfolio, ranked #286.

Mizuho Securities USA first reported a position in EW in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.29M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mizuho Securities USA held 45,079 shares of Edwards Lifesciences worth $4.08M as of Q2 2026.
  • Mizuho Securities USA bought 9,997 Edwards Lifesciences shares in Q2 2026, an estimated $837K.
  • Edwards Lifesciences made up 0.07% of Mizuho Securities USA's portfolio in Q2 2026, its #286 holding.
  • Mizuho Securities USA first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 9 quarters since.
  • Mizuho Securities USA's Edwards Lifesciences position peaked at $4.29M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.